Green Dye 3 vs Propylene Glycol: which is worse?

What is Green Dye 3?

Green Dye 3 (Fast Green FCF) is a synthetic blue-green triarylmethane dye similar to Blue Dye 1. It produces a sea-green color and is among the least used certified US food dyes. Its chemical formula is C37H34N2Na2O10S3.

What is Propylene Glycol?

Propylene glycol is a synthetic organic compound used as a humectant, solvent, and emulsifier in food, pharmaceuticals, cosmetics, and industrial applications. It is produced from propylene oxide (derived from petroleum). Its chemical formula is C3H8O2.

Documented risks

Green Dye 3: Green Dye 3 has a limited safety database compared to other certified food dyes, partly due to its infrequent use. A 1981 NTP bioassay (Technical Report 27) found statistically significant increases in urinary bladder tumors in male mice at high doses. The FDA reviewed these findings and, as with Blue 2, concluded the doses far exceeded typical human dietary exposure. Green 3 is not approved in the EU — under the EU's positive list system, only specifically approved additives may be used. Since Green 3 is not on the positive list, it is effectively banned. EFSA has not conducted a formal re-evaluation because it is not authorized for EU use. Hypersensitivity reactions have been reported. Like other synthetic triarylmethane dyes, Green 3 may cause contact dermatitis. The FDA's April 2025 phase-out announcement includes Green 3 among the eight petroleum-based synthetic dyes to be removed from the US food supply. Its already limited use means this phase-out has minimal market impact compared to Red 40 or Yellow 5.

Propylene Glycol: Propylene glycol is generally considered safe by the FDA and is metabolized by the liver to lactic acid and pyruvate (normal metabolites). However, at high doses — particularly from intravenous pharmaceutical formulations — propylene glycol can accumulate and cause lactic acidosis, kidney toxicity, and CNS effects. These effects are seen in critically ill patients receiving high-dose PG-containing intravenous medications, not from food consumption. In children and people with impaired liver or kidney function, PG accumulation may occur at lower doses than in healthy adults. Animal studies have found reproductive and developmental effects at high doses. EFSA's 2018 re-evaluation found no concerns at typical food use levels but noted the EU limits PG use as a direct food additive, using it only as a carrier solvent for permitted additives.